Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating the effectiveness of Uganda's Supranational TB Reference Laboratory quality management system training program.
Dorothy N, Niringiyimana B, Enock W, Guido O, Joel K, Isa A, Katuramu A, Beatrice O, Korsah CN, Kyomugasho L, Oola D, Musisi K, Kim E, Yu N, Kaliisa R, Lee Y, Kim B, Ronald S, Kiwanuka N, Achilles K, Joloba ML. Dorothy N, et al. Among authors: musisi k. Hum Resour Health. 2023 Nov 21;21(1):89. doi: 10.1186/s12960-023-00876-8. Hum Resour Health. 2023. PMID: 37990265 Free PMC article.
Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
Kabugo J, Namutebi J, Mujuni D, Nsawotebba A, Kasule GW, Musisi K, Kigozi E, Nyombi A, Lutaaya P, Kangave F, Joloba ML. Kabugo J, et al. Among authors: musisi k. PLoS One. 2021 May 14;16(5):e0251691. doi: 10.1371/journal.pone.0251691. eCollection 2021. PLoS One. 2021. PMID: 33989348 Free PMC article.
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM, Kabugo J, Kakooza F, Adam I, Guido O, Byabajungu H, Namutebi J, Namaganda MM, Lutaaya P, Otim J, Kakembo FE, Kanyerezi S, Nabisubi P, Sserwadda I, Kasule GW, Nakato H, Musisi K, Oola D, Joloba ML, Mboowa G. Kabahita JM, et al. Among authors: musisi k. Antimicrob Resist Infect Control. 2022 May 12;11(1):68. doi: 10.1186/s13756-022-01101-2. Antimicrob Resist Infect Control. 2022. PMID: 35550202 Free PMC article.
Impact of randomized blinded rechecking program on the performance of the AFB Microscopy Laboratory Network in Uganda: a decadal retrospective study.
Nsawotebba A, Ibanda I, Mujuni D, Nabadda S, Nadunga D, Kabugo J, Adam I, Wekiya E, Nyombi A, Nsubuga R, Ademun P, Musisi K, Kangave F, Joloba M. Nsawotebba A, et al. Among authors: musisi k. BMC Infect Dis. 2023 Jul 26;23(1):494. doi: 10.1186/s12879-023-08406-6. BMC Infect Dis. 2023. PMID: 37495964 Free PMC article.
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
Kateete DP, Kamulegeya R, Kigozi E, Katabazi FA, Lukoye D, Sebit SI, Abdi H, Arube P, Kasule GW, Musisi K, Dlamini MG, Khumalo D, Joloba ML. Kateete DP, et al. Among authors: musisi k. BMC Pulm Med. 2019 Jul 10;19(1):124. doi: 10.1186/s12890-019-0891-x. BMC Pulm Med. 2019. PMID: 31291943 Free PMC article.
15 results